Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Iridex (IRIX) Notes Payables (2016 - 2024)

Iridex has reported Notes Payables over the past 7 years, most recently at $1.7 million for Q4 2024.

For Q4 2024, Notes Payables changed N/A year-over-year to $1.7 million; the TTM value through Dec 2024 reached $1.7 million, changed N/A, while the annual FY2024 figure was $1.7 million, N/A changed from the prior year.
Notes Payables for Q4 2024 was $1.7 million at Iridex, up from $1.3 million in the prior quarter.
Over five years, Notes Payables peaked at $1.7 million in Q4 2024 and troughed at $1.3 million in Q3 2024.